Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,340
Closed -$11K 811
2018
Q3
$11K Buy
2,340
+130
+6% +$620 ﹤0.01% 482
2018
Q2
$10K Sell
2,210
-2,230
-50% -$13.1K ﹤0.01% 451
2018
Q1
$32K Buy
4,440
+2,230
+101% +$15.3K 0.01% 321
2017
Q4
$14K Hold
2,210
﹤0.01% 421
2017
Q3
$15K Hold
2,210
﹤0.01% 410
2017
Q2
$12K Hold
2,210
﹤0.01% 439
2017
Q1
$13K Buy
2,210
+231
+12% +$1.27K ﹤0.01% 425
2016
Q4
$10K Hold
1,979
﹤0.01% 493
2016
Q3
$12K Buy
1,979
+889
+82% +$5.32K ﹤0.01% 459
2016
Q2
$6K Buy
+1,090
New +$5.85K ﹤0.01% 563

Other funds holding ABEV

Howe & Rusling's ABEV Position: Q4 2018 in Review

Howe & Rusling sold out of Ambev (ABEV) in Q4 2018, closing a stake of 2,340 shares — an estimated $11K sold.

Howe & Rusling first reported a position in ABEV in Q2 2016 and held it in 10 quarters. The position peaked at $32K in Q1 2018. 318 funds tracked by Wall St. Rank hold ABEV as of Q4 2018.

  • Howe & Rusling reported no remaining Ambev position as of Q4 2018 after selling out during the quarter.
  • Howe & Rusling sold 2,340 Ambev shares in Q4 2018, an estimated $11K.
  • Howe & Rusling first reported a position in Ambev in Q2 2016 and held it in 10 quarters.
  • Howe & Rusling's Ambev position peaked at $32K in Q1 2018.
  • 318 funds tracked by Wall St. Rank held Ambev as of Q4 2018.

Based on Howe & Rusling's 13F filing for Q4 2018, filed 4 Feb 2019.